| Main Menu   | Home  |  About Us  |  What's New | FAQSite Search   | Contact Us   |  Books  | Privacy Policy | 

 

A Textbook on EDTA Chelation Therapy, Second Edition

Edited by Elmer M. Cranton, M.D.
Foreword by Linus Pauling, Ph.D.

Photo of textbook cover

Chelation therapy using intravenous infusion of EDTA is a highly effective treatment for atherosclerotic cardiovascular disease. Safety and effectiveness are well documented in clinical studies, all of which to date are supportive of this therapy. There are no studies showing lack of effectiveness. Strong evidence is presented to support the use of this safe, efficacious, and inexpensive therapy before resorting to surgery and other risky, invasive treatments.

This is an extensively revised and updated edition of is regarded as the definitive textbook on this subject. Renowned chelation expert, Elmer M. Cranton, M.D., presents a compendium of research by the world's leading experts in chelation therapy. Many clinical trials are republished as chapters.

"This therapy has been proven effective over and over again in clinical practice," says Dr. Cranton. "More than one million patients have received more than twenty million infusions with great benefit and without serious adverse effects."

Click here for discount order

In his foreword, two-time Nobel Prize winner Dr. Linus Pauling states, "EDTA chelation therapy makes good sense to me as a chemist and medical researcher. It has a rational scientific basis, and the evidence for clinical benefit seems to be quite strong."

Here in a single volume you will learn everything you need to know to responsibly administer and advocate chelation therapy. You will find a coherent scientific rationale, clinical trials, all of which demonstrate effectiveness, guidelines for safety, detailed protocols for administration, laboratory testing, and techniques for pre­ and post-treatment evaluation.


A Textbook on EDTA Chelation Therapy, pp. 563, Published 2001 List Price $75.00
but now available at a discount

A full text copy of Chapter 35 is can be downloaded from the link below.
 

Scroll down to to read the titles and authors of all 38 chapters


TABLE OF CONTENTS

FOREWORD
Linus Pauling, PhD

INTRODUCTION TO SECOND EDITION
Elmer M. Cranton, MD

SECTION 1: SCIENTIFIC RATIONALE

Chapter 1
SCIENTIFIC RATIONALE FOR EDTA CHELATION THERAPY IN TREATMENT OF ATHEROSCLEROSIS AND DISEASES OF AGING
Elmer M. Cranton, M.D. and James P. Frackelton, M.D.

Chapter 2
IRON AND ISCHEMIC HEART DISEASE
Jerome L. Sullivan, MD, PhD

Chapter 3
THE CROSSLINKAGE THEORY OF AGING AS A PREDICTIVE INDICATOR
Johan Bjorksten, PhD

Chapter 4
POSSIBILITIES AND LIMITATIONS OF CHELATION AS A MEANS FOR LIFE EXTENSION
Johan Bjorksten, PhD

Chapter 5
NUTRITIONAL FACTORS IN CARDIOVASCULAR DISEASE
Alan R. Gaby, MD

SECTION II: CLINICAL TRIALS

Chapter 6
CURRENT STATUS OF EDTA CHELATION THERAPY IN OCCLUSIVE ARTERIAL DISEASE
Elmer M. Cranton, MD and James P. Frackelton, MD

Chapter 7
EDTA CHELATION THERAPY: EFFICACY IN ARTERIOSCLEROTIC HEART DISEASE
H. Richard Casdorph, MD, PhD

Chapter 8
EDTA CHELATION THERAPY: EFFICACY IN BRAIN DISORDERS
H. Richard Casdorph, MD, PhD

Chapter 9
AN OCULOCEREBROVASCULOMETRIC ANALYSIS OF THE IMPROVEMENT IN ARTERIAL STENOSIS FOLLOWING EDTA CHELATION THERAPY
Edward W. McDonagh, DO, Charles J. Rudolph, DO, PhD, and E. Cheraskin, MD, DMD

Chapter 10
EFFECT OF EDTA CHELATION THERAPY PLUS MULTIVITAMIN TRACE MINERAL SUPPLEMENTATION UPON VASCULAR DYNAMICS: ANKLE/BRACHIAL DOPPLER SYSTOLIC BLOOD PRESSURE RATIO
Edward W. McDonagh, DO, Charles J. Rudolph, DO, PhD, and E. Cheraskin, MD, DMD

Chapter 11
EDTA CHELATION THERAPY: TREATMENT OF PERIPHERAL ARTERIAL OCCLUSION, AN ALTERNATIVE TO AMPUTATION
H. Richard Casdorph, MD, PhD, and Charles H. Farr, MD, PhD

Chapter 12
NINETY PERCENT REDUCTION IN CANCER MORTALITY AFTER CHELATION THERAPY WITH EDTA
Walter Blumer, MD and Elmer M. Cranton, MD

Chapter 13
THE "CLINICAL CHANGE" IN PATIENTS TREATED WITH EDTA CHELATION PLUS MULTIVITAMIN/TRACE MINERAL SUPPLEMENTATION
Edward W. McDonagh, DO, Charles J. Rudolph, DO, PhD, and E. Cheraskin, MD, DMD

Chapter 14
EDTA CHELATION THERAPY: A RETROSPECTIVE STUDY OF 2,870 PATIENTS
Efrain Olszewer, MD and James P. Carter, MD, DrPH

Chapter 15
BENEFITS OF EDTA CHELATION THERAPY ON ATHEROSCLEROSIS: A RETROSPECTIVE STUDY OF 470 PATIENTS.
Claus Hancke, and Knut Flythe

Chapter 16
VISUAL FIELD EVIDENCE OF MACULAR DEGENERATION REVERSAL USING A COMBINATION OF EDTA CHELATION AND MULTIPLE VITAMIN AND TRACE MINERAL THERAPY.
Charles J. Rudolph, DO, PhD, R. T. Samuels, and Edward W. McDonagh, DO

Chapter 17
A NONSURGICAL APPROACH TO OBSTRUCTIVE CAROTID STENOSIS. USING EDTA CHELATION.
Charles J. Rudolph, DO, PhD, and Edward W. McDonagh, DO, and R.K. Barber

Chapter 18
THE EFFECT OF INTRAVENOUS DISODIUM ETHYLENEDIAMINETETAACETIC ACID (EDTA) UPON BONE DENSITY.
Charles J. Rudolph, DO, PhD, and Edward W. McDonagh, DO, D. G. Wussow

Chapter 19
RENAL ARTERY STENOSIS REVERSAL IN A HYPERTENSIVE INDIVIDUAL, USING A COMBINATION OF EDTA CHELATION AND MULTIPLE VITAMIN AND TRACE MINERAL THERAPY.
Charles J. Rudolph, DO, PhD, and Edward W. McDonagh, DO

Chapter 20
THE EFFECT OF EDTA CHELATION THERAPY WITH MULTIVITAMIN/TRACE MINERAL SUPPLEMENTATION UPON REPORTED FATIGUE.
Edward W. McDonagh, DO, Charles J. Rudolph, DO, PhD, and E. Cheraskin, MD, DMD

Chapter 21
CLINICAL IMPROVEMENTS AS JUDGED BY THE CORNELL MEDICAL INDEX QUESTIONNAIRE IN PATIENTS TREATED WITH EDTA CHELATION THERAPY
H. D. Riordan, MD, E. Cheraskin, MD, DMD, and M. Dirks, BD

Chapter 22
A PILOT DOUBLE BLIND STUDY OF SODIUM-MAGNESIUM EDTA IN PERIPHERAL VASCULAR DISEASE.
Efrain Olszewer, MD, F. C. Sabbag, and James P. Carter

Chapter 23
THE CORRELATION BETWEEN EDTA CHELATION THERAPY AND IMPROVEMENT IN CARDIOVASCULAR FUNCTION: A META-ANALYSIS.
L. Terry Chappell, and J.P. Stahl

Chapter 24
EDTA CHELATION TREATMENT FOR VASCULAR DISEASE: A META-ANALYSIS USING UNPUBLISHED DATA.
L. Terry Chappell, J.P. Stahl, and R. Evans

Chapter 25
IF EDTA CHELATION THERAPY IS SO GOOD, WHY IS IT NOT MORE WIDELY ACCEPTED?
James P. Carter, MD, DrPH

SECTION III: SAFETY

Chapter 26
KIDNEY EFFECTS OF ETHYLENE DIAMINE TETRAACETIC ACID (EDTA): A LITERATURE REVIEW
Elmer M. Cranton, MD

Chapter 27
THE EFFECT OF EDTA CHELATION THERAPY PLUS SUPPORTIVE MULTIVITAMIN‑TRACE-MINERAL SUPPLEMENTATION UPON RENAL FUNCTION: A STUDY IN SERUM CREATININE
Edward W. McDonagh, DO, Charles J. Rudolph, DO, PhD, and E. Cheraskin, MD, DMD

Chapter 28
THE IMPROVEMENT IN RENAL FUNCTION FOLLOWING EDTA CHELATION AND MULTIVITAMIN TRACE-MINERAL THERAPY: A STUDY IN CREATININE CLEARANCE
Keith W. Sehnert, MD, A. F. Clague, and E. Cheraskin, MD, DMD

Chapter 29
THE EFFECT OF EDTA CHELATION THERAPY PLUS SUPPORTIVE MULTIVITAMIN-TRACE MINERAL SUPPLEMENTATION UPON RENAL FUNCTION: A STUDY IN BLOOD UREA NITROGEN (BUN)
Edward W. McDonagh, DO, Charles J. Rudolph, DO, PhD, and E. Cheraskin, MD, DMD

Chapter 30
ANOTHER LOOK AT RENAL FUNCTION AND THE EDTA CHELATION TREATMENT PROCESS
H. D. Riordan, MD, E. Cheraskin, MD, DMD, M. Dirks, BD, MA, M. Schultz, ARNP, and P. Brizendine, ARNP

SECTION IV: HISTORY AND PROTOCOL FOR ADMINISTRATION

Chapter 31
Overview, Historical Background and Current Status of EDTA Chelation Therapy for Atherosclerosis
Michael B. Schachter, MD

Chapter 32
THE PROTOCOL FOR THE SAFE AND EFFECTIVE ADMINISTRATION OF EDTA AND OTHER CHELATING AGENTS FOR VASCULAR AND DEGENERATIVE DISEASES
Theodore C. Rozema

Chapter 33
IRON AND COPPER SUPPLEMENTATION WITH EDTA CHELATION THERAPY
James P. Frackelton, MD and Elmer M. Cranton, MD

SECTION V: LABORATORY EVALUATION

Chapter 34
A LABORATORY METHOD TO MEASURE PLASMA EDTA LEVELS.
Zheng Xian Liu, K. C. Harich, and Elmer M. Cranton, MD

Chapter 35         (Full text available for download)
MONITORING RENAL FUNCTION AND DOSE COMPUTATION DURING EDTA CHELATION THERAPY

Elmer M. Cranton, M.D. and James P. Frackelton, MD

Chapter 36
URINARY TRACE AND TOXIC ELEMENTS AND MINERALS IN UNTIMED URINE SPECIMENS RELATIVE TO URINE CREATININE, PART I: CONCENTRATIONS OF ELEMENTS IN FASTING URINE
Elmer M. Cranton, MD Zheng Xian Liu, MS, and Ivy M. Smith, MT

Chapter 37
URINARY TRACE AND TOXIC ELEMENTS AND MINERALS IN UNTIMED URINE SPECIMENS RELATIVE TO URINE CREATININE, PART II: PROVOKED INCREASE IN EXCRETION FOLLOWING INTRAVENOUS EDTA
Elmer M. Cranton, MD Zheng Xian Liu, MS, and Ivy M. Smith, MT

Chapter 38
TESTING FOR TOXIC ELEMENTS AND CHELATION OF MERCURY
Elmer M. Cranton, M.D.

Click Here for discount Order!

Copyright © 2012 Elmer M. Cranton, M.D., all rights reserved

Last modified: